SEC Form 4 · accession 0000899243-19-006157
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Hunt
Officer — Chief Executive Officer · Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 5, 2019 | S | 13,000 | $58.50 | D | 229,657 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of 13,000 shares in the open market to cover tax liability resulting from the release of restricted stock units.
- F2$58.50 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.17 to $59.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.